Condition: Kidney Disease

A Multicentre International Randomized Parallel Group Double-blind Placebo-controlled Clinical Trial of EMPAgliflozin Once Daily to Assess Cardio-renal Outcomes in Patients With Chronic KIDNEY Disease

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Lake CIty, Macon

Condition: Kidney Disease